INFU - InfuSystem Holdings Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
2.70
+0.10 (+3.85%)
At close: 3:26PM EDT
Stock chart is not supported by your current browser
Previous Close2.60
Open2.65
Bid0.00 x 0
Ask0.00 x 0
Day's Range2.65 - 2.75
52 Week Range1.20 - 2.95
Volume5,649
Avg. Volume26,688
Market Cap61.576M
Beta0.27
PE Ratio (TTM)N/A
EPS (TTM)-0.91
Earnings DateMay 11, 2017 - May 12, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.00
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEventslast month

    Edited Transcript of INFU earnings conference call or presentation 13-Mar-18 2:00pm GMT

    Q4 2017 InfuSystem Holdings Inc Earnings Call

  • GlobeNewswirelast month

    InfuSystem Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2017 Results

    MADISON HEIGHTS, MICHIGAN, March 13, 2018-- InfuSystem Holdings, Inc., a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, reported ...

  • InfuSystem to Report Fourth Quarter 2017 Financial Results on Tuesday, March 13, 2018
    PR Newswire2 months ago

    InfuSystem to Report Fourth Quarter 2017 Financial Results on Tuesday, March 13, 2018

    Investor Conference Call to be held at 10:00 a.m. Eastern Time MADISON HEIGHTS, Mich. , March 6, 2018 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE American: INFU), a leading national provider of infusion ...

  • InfuSystem Holdings, Inc. Reports Interim Chief Financial Officer Will Leave Company at End of Current Quarter
    PR Newswire2 months ago

    InfuSystem Holdings, Inc. Reports Interim Chief Financial Officer Will Leave Company at End of Current Quarter

    MADISON HEIGHTS, Mich., Feb. 7, 2018 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, today announced that its interim chief financial officer, Christopher Downs, has informed the Company of his decision to resign his position with the Company, effective March 31, 2018.  Mr. Downs resignation does not reflect any dispute or disagreement with the Company, nor does it relate to any issues with respect to the Company's financial performance.

  • InfuSystem Holdings, Inc. Announces Dismissal of Class Action Shareholder Lawsuit
    PR Newswire3 months ago

    InfuSystem Holdings, Inc. Announces Dismissal of Class Action Shareholder Lawsuit

    MADISON HEIGHTS, Mich., Jan. 31, 2018 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national provider of infusion pumps and related services for the healthcare industry in the United States, announced today it has received notice that on January 29, 2018 the United States District Court for the Central District of California has issued an order dismissing, with prejudice, a putative class-action lawsuit against the Company.

  • Capital Cube4 months ago

    ETFs with exposure to InfuSystem Holdings, Inc. : December 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to InfuSystem Holdings, Inc. Here are 5 ETFs with the largest exposure to INFU-US. Comparing the performance and risk of InfuSystem Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of INFU earnings conference call or presentation 10-Nov-17 4:00pm GMT

    Q3 2017 InfuSystem Holdings Inc Earnings Call

  • Richard DiIorio Appointed as President and Chief Executive Officer of InfuSystem Holdings, Inc.
    PR Newswire5 months ago

    Richard DiIorio Appointed as President and Chief Executive Officer of InfuSystem Holdings, Inc.

    MADISON HEIGHTS, Mich., Nov. 16, 2017 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading provider of infusion pumps and related services for the healthcare industries in the United States and Canada, announced the appointment of Richard DiIorio as President and Chief Executive Officer, effective November 15, 2017. Mr. DiIorio has been elected to serve on InfuSystem's Board of Directors. With Mr. DiIorio's appointment, the Office of the President will cease to operate.

  • ACCESSWIRE5 months ago

    InfuSystem Holdings, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 10, 2017 / InfuSystem Holdings, Inc. (NYSE American: INFU ) will be discussing their earnings results in their Q3 Earnings Call to be held on Friday, November 10, 2017 ...

  • InfuSystem Holdings, Inc. Reports Third Quarter 2017 Financial Results
    PR Newswire5 months ago

    InfuSystem Holdings, Inc. Reports Third Quarter 2017 Financial Results

    AEBITDA increased 13%, compared to the third quarter of 2016 and 26%, compared to the second quarter of 2017 The Company reduced net debt by $2.9 million during the quarter and $4.7 million from December ...

  • InfuSystem To Issue Third Quarter 2017 Financial Results On Friday, November 10, 2017, Before The Market Opens
    PR Newswire6 months ago

    InfuSystem To Issue Third Quarter 2017 Financial Results On Friday, November 10, 2017, Before The Market Opens

    Investor Conference Call to be Held at 11:00 a.m. Eastern Time on Friday, November 10, 2017 MADISON HEIGHTS, Mich. , Oct. 31, 2017 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE American: INFU), a leading ...

  • Is InfuSystem Holdings Inc’s (INFU) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.6 months ago

    Is InfuSystem Holdings Inc’s (INFU) Balance Sheet Strong Enough To Weather A Storm?

    Investors are always looking for growth in small-cap stocks like InfuSystem Holdings Inc (AMEX:INFU), with a market cap of USD $46.65M. However, an important fact which most ignore is: howRead More...

  • Lifetime TV Highlights the Quality of Life InfuSystem Oncology Therapy Can Provide
    PR Newswire6 months ago

    Lifetime TV Highlights the Quality of Life InfuSystem Oncology Therapy Can Provide

    MADISON HEIGHTS, Mich., Oct. 18, 2017 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading provider of oncology infusion pumps and related services in North America, announced a feature segment that recently ran on a leading cable TV channel highlighting how InfuSystem infusion technology improves the quality of life of a patient going through the process of receiving chemotherapy. Entitled "At-Home Infusion Made Easy," the segment ran on "The Balancing Act" Lifetime TV morning show on October 5th. Featured in the segment is one of the over 300,000 new patients with gastrointestinal cancers that are estimated by the American Cancer Society to be diagnosed annually in the U.S. InfuSystem treats a large number of these patients with hardware, medication and services that serve as the gold standard in the industry.

  • Capital Cube6 months ago

    ETFs with exposure to InfuSystem Holdings, Inc. : October 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to InfuSystem Holdings, Inc. Here are 5 ETFs with the largest exposure to INFU-US. Comparing the performance and risk of InfuSystem Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • InfuSystem Holdings, Inc. :INFU-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
    Capital Cube7 months ago

    InfuSystem Holdings, Inc. :INFU-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017

    Categories: Yahoo FinanceGet free summary analysis InfuSystem Holdings, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 16.94 million, Net Earnings of USD -1.11 million. Gross margins narrowed from 55.85% to 52.26% compared to the same period last year, operating (EBITDA) margins now 11.78% from 16.88%. Narrowing of operating ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of INFU earnings conference call or presentation 9-Aug-17 8:30pm GMT

    Q2 2017 InfuSystem Holdings Inc Earnings Call

  • InfuSystem Holdings, Inc. Reports Second Quarter 2017 Financial Results
    PR Newswire8 months ago

    InfuSystem Holdings, Inc. Reports Second Quarter 2017 Financial Results

    The Company reduced net debt by $2.9 million during the quarter; AEBITDA increased 113% compared to the first quarter of 2017 MADISON HEIGHTS, Mich. , Aug. 9, 2017 /PRNewswire/ -- InfuSystem Holdings, ...

  • InfuSystem To Issue Second Quarter 2017 Financial Results On Wednesday, August 9, 2017 After The Market Close
    PR Newswire9 months ago

    InfuSystem To Issue Second Quarter 2017 Financial Results On Wednesday, August 9, 2017 After The Market Close

    Investor Conference Call to be Held at 4:30 p.m. Eastern Time on Wednesday, August 9, 2017 MADISON HEIGHTS, Mich. , Aug. 4, 2017 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading national ...

  • Marketwired9 months ago

    Moleculin Strengthens Board of Directors with Appointment of John M. Climaco

    Moleculin Biotech, Inc., , a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System......

  • InfuSystem Announces the Election of Darrell Montgomery and Christopher Sansone to Board of Directors
    PR Newswire10 months ago

    InfuSystem Announces the Election of Darrell Montgomery and Christopher Sansone to Board of Directors

    MADISON HEIGHTS, Mich., June 22, 2017 /PRNewswire/-- InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or the "Company"), a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, announced today that Darrell B. Montgomery and Christopher R. Sansone have been elected as new members to the Company's Board of Directors at the 2017 annual meeting of its stockholders on June 22, 2017. Darrell Montgomery and Christopher Sansone will hold office until they stand for re-election at InfuSystem's next annual shareholders meeting in 2018.

  • Capital Cube10 months ago

    ETFs with exposure to InfuSystem Holdings, Inc. : June 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to InfuSystem Holdings, Inc. Here are 5 ETFs with the largest exposure to INFU-US. Comparing the performance and risk of InfuSystem Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • InfuSystem's Board Of Directors Rejects 22NW Fund's Unsolicited Proposal As Inadequate
    PR Newswire10 months ago

    InfuSystem's Board Of Directors Rejects 22NW Fund's Unsolicited Proposal As Inadequate

    MADISON HEIGHTS, Mich., June 19, 2017 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or the "Company"), a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, announced today that its Board of Directors, with the assistance of legal counsel, has carefully reviewed 22NW Fund, LP's unsolicited proposal and determined that the $2.00 per share proposal is inadequate and that pursuing such a transaction at the present time is not in the best interests of InfuSystem's stockholders. Accordingly, the Board of Directors has rejected 22NW Fund's proposal.

  • PR Newswire10 months ago

    22NW Fund Makes All Cash $2.00 Offer for InfuSystem Holdings (INFU)

    SEATTLE, June 19, 2017 /PRNewswire/ -- 22NW Fund, LP, an investment partnership with more than $200 million under management, announced today that it had transmitted a letter to the Board of InfuSystem Holdings Inc. (INFU) to acquire all outstanding shares of INFU for $2.00 per share. 22NW's proposal is an all cash offer, subject to customary due diligence, regulatory approval, and financing, which 22NW Fund believes is readily available. The offer represents a premium of 29% from the close on June 12th, 2017, the day after the offer was transmitted, and would deliver immediate, certain value to INFU's shareholders.